about
MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosisKinetic and spectroscopic characterization of the putative monooxygenase domain of human MICAL-1Structure of the Repulsive Guidance Molecule (RGM)-Neogenin Signaling HubMICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsionSemaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrinDevelopmental and activity-dependent miRNA expression profiling in primary hippocampal neuron culturesWnt/planar cell polarity signaling controls the anterior-posterior organization of monoaminergic axons in the brainstemSemaphorin junction: making tracks toward neural connectivityThe intracellular redox protein MICAL-1 regulates the development of hippocampal mossy fibre connectionsdcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients.Neuropeptide delivery to the brain: a von Willebrand factor signal peptide to direct neuropeptide secretion.High-resolution structure of the catalytic region of MICAL (molecule interacting with CasL), a multidomain flavoenzyme-signaling moleculeDysregulation of Semaphorin7A/β1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertilitySpatiotemporal expression of repulsive guidance molecules (RGMs) and their receptor neogenin in the mouse brain.Semaphorin7A regulates neuroglial plasticity in the adult hypothalamic median eminenceMicrotubule minus-end binding protein CAMSAP2 controls axon specification and dendrite development.MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering Semaphorin 3F function.Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune responseEndocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits.S-nitrosylation of HDAC2 regulates the expression of the chromatin-remodeling factor Brm during radial neuron migration.Getting connected in the dopamine system.Semaphorin signaling: progress made and promises ahead.Semaphorin function in neural plasticity and disease.Axon guidance in the dopamine system.Protein aggregation in amyotrophic lateral sclerosis.Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?Semaphorin signalling during development.Axon guidance proteins in neurological disorders.Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson's disease.Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons.CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor.A double hit implicates DIAPH3 as an autism risk gene.Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment.Frizzled3 Controls Axonal Polarity and Intermediate Target Entry during Striatal Pathway Development.DeActs: genetically encoded tools for perturbing the actin cytoskeleton in single cells.shRNA-induced saturation of the microRNA pathway in the rat brain.Transcriptional repression of Plxnc1 by Lmx1a and Lmx1b directs topographic dopaminergic circuit formation.FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands.unc5c haploinsufficient phenotype: striking similarities with the dcc haploinsufficiency model.
P50
Q24311439-E0E6CBFC-7613-4DCF-82D5-7C920504EC5DQ24328953-B204CAD1-F6BC-497F-A3E3-2B422FAE4771Q27678519-ACDF1EBF-AF65-40DF-AF55-D81BE5E670B0Q28213990-ACF07E37-C569-4217-BA9C-0F766CE5D8DBQ28507882-59BF851B-3F05-4578-8345-7A9AF9698AD3Q28534050-B912A61D-E26E-462D-B52C-430190FB72F2Q28587219-F77855C0-321A-429B-BC09-5F4FEA15CD33Q28646139-87D0606F-CB22-414D-9A82-1133D6EEAB3BQ28975620-0B473C6F-9EE0-40C4-A7C7-9A0860768BE1Q30437910-B026E7BB-92D7-4232-84D7-5FEA64781331Q33654734-98CBCC61-016A-42FA-91E0-6272598B338AQ34120510-05F3EBDB-6F4B-44BE-9482-EF3CAF4BE4EEQ34214766-659F9817-411A-4D8D-92DD-744D0E62717CQ34606393-26ADA2C1-D5BB-47F6-A4FA-E37AD2BCEF42Q35153378-E9D57096-8160-43BA-9570-E8033B09CC69Q35183547-D1C030DD-CE3A-46FE-8EBE-6FB183FB6E8FQ35790342-C41877F5-1994-4C74-9ED0-91B5997407FCQ36192088-4B779101-9121-499B-916D-2F17A9B32BAAQ36395277-EA54AF8E-FC80-40DD-8535-4CDBCA272EECQ36555249-378FA95F-3187-4664-A1E1-1AD0C5644BEEQ36637329-00C78CEA-EE3A-4E75-AA1A-0ACAB42CF377Q37096350-9DFCDAA8-6DF5-403F-BA14-4B1946133328Q37122271-03A984B2-FB4B-45DD-AB0E-388C34D84B31Q37525595-9680D237-E74F-4614-8505-E2641F995C3AQ37592112-3BC99888-02A6-46A6-8F6F-6FA984C8E9E0Q38106862-F559888F-460D-42BB-9593-1C739AEDE2A2Q38154020-F43FD118-BFE1-4549-B9BD-1399119FDEB6Q38241511-2F16A6B5-D403-46D0-BB2C-2455F9A029C1Q38376932-51D5B3E8-526D-4379-A947-1D9B220E0A07Q38607716-E0809451-288A-455C-838B-ED991879CAB6Q38752574-3B4301AD-1EF5-4DD0-9E1B-A8888FA41E0FQ39080254-20913CAD-65E0-49CC-8B8A-ECC89D12C433Q39724547-A6A0BE32-5122-4A08-95F3-8EB14158B393Q40083141-310D200B-44E9-4C3C-AC3C-A3CC2D95C6FFQ40404398-7F8299BD-A519-4D1B-BD9C-CAEBF96C32D2Q42172880-AE6C3E17-EF80-43CC-992A-3BF9D428FACEQ42245600-DFDAD24C-E98B-4D00-80B6-B4C75AA00392Q42378846-AC33182D-87DD-4324-A963-962D9658479EQ43506728-514C438F-EA59-4311-A56C-85EE1E0E5B42Q45897060-A6B52FC9-9C65-4DF1-9833-249275A897B8
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
R Jeroen Pasterkamp
@ast
R Jeroen Pasterkamp
@en
R Jeroen Pasterkamp
@nl
type
label
R Jeroen Pasterkamp
@ast
R Jeroen Pasterkamp
@en
R Jeroen Pasterkamp
@nl
prefLabel
R Jeroen Pasterkamp
@ast
R Jeroen Pasterkamp
@en
R Jeroen Pasterkamp
@nl
P106
P31
P496
0000-0003-1631-6440